Thus, VISTA blockade in the tumor microenvironment may change the anti-inflammatory context during uptake of VISTA+ tumor cells and thereby impeding the subsequent suppression of T cell immune responses induced by VISTA+ phagocytes. Here, VSIR is linked to neoplasm.